A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1016/j.celrep.2016.09.079
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2016
- Urheber
-
Tzelepis, Konstantinos
Koike-Yusa, Hiroko
De Braekeleer, Etienne
Li, Yilong
Metzakopian, Emmanouil
Dovey, Oliver M.
Mupo, Annalisa
Grinkevich, Vera
Li, Meng
Mazan, Milena
Gozdecka, Malgorzata
Ohnishi, Shuhei
Cooper, Jonathan
Patel, Miten
McKerrell, Thomas
Chen, Bin
Domingues, Ana Filipa
Gallipoli, Paolo
Teichmann, Sarah A.
Ponstingl, Hannes
McDermott, Ultan
Saez-Rodriguez, Julio
Huntly, Brian J. P.
Iorio, Francesco
Pina, Cristina
Vassiliou, George S.
Yusa, Kosuke
- DOI
-
10.18154/RWTH-CONV-212180
- URN
-
urn:nbn:de:101:1-2019092605503126931557
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tzelepis, Konstantinos
- Koike-Yusa, Hiroko
- De Braekeleer, Etienne
- Li, Yilong
- Metzakopian, Emmanouil
- Dovey, Oliver M.
- Mupo, Annalisa
- Grinkevich, Vera
- Li, Meng
- Mazan, Milena
- Gozdecka, Malgorzata
- Ohnishi, Shuhei
- Cooper, Jonathan
- Patel, Miten
- McKerrell, Thomas
- Chen, Bin
- Domingues, Ana Filipa
- Gallipoli, Paolo
- Teichmann, Sarah A.
- Ponstingl, Hannes
- McDermott, Ultan
- Saez-Rodriguez, Julio
- Huntly, Brian J. P.
- Iorio, Francesco
- Pina, Cristina
- Vassiliou, George S.
- Yusa, Kosuke
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2016
Ähnliche Objekte (12)
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
Vulnerabilities
Identification of myeloid cell targets for cancer immunotherapy using CRISPR screening
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
A platform of patient-derived microtumors identifies individual treatment responses and therapeutic vulnerabilities in ovarian cancer
Molecular dissection of normal and malignant hematopoiesis identifies therapeutic targets in myeloid neoplasms
Fiscal-financial vulnerabilities
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
Vulnerabilities
Identification of myeloid cell targets for cancer immunotherapy using CRISPR screening
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
A platform of patient-derived microtumors identifies individual treatment responses and therapeutic vulnerabilities in ovarian cancer
Molecular dissection of normal and malignant hematopoiesis identifies therapeutic targets in myeloid neoplasms
Fiscal-financial vulnerabilities
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
CRISPR/Cas9 library screening identifies PIP4K2C as regulator of PVR
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
Vulnerabilities
Identification of myeloid cell targets for cancer immunotherapy using CRISPR screening
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
Complementary CRISPR screen identifies novel mechanisms of cytotoxic T cell inhibition by tumor cells
A platform of patient-derived microtumors identifies individual treatment responses and therapeutic vulnerabilities in ovarian cancer
Molecular dissection of normal and malignant hematopoiesis identifies therapeutic targets in myeloid neoplasms